Chang Carmen

Director, 10% owner at NEUE; Director at COUR; 10% owner at GENOCEA BIOSCIENCES, INC., and 2 more

Sold, on record
$1.3M
Dollars the filings state
Form 4 sales
5
Latest Oct 2, 2025
Form 144 notices
0
Proposed sales
Companies
5
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TRVIPlan not stated
    Apr 3 2020

    Sold 564 shares at $2.66 ($2k)

    Chang Carmen, 10% owner

    Sold 0% of holdings ($15.8M position)5.9M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Metacrine, Inc.Plan not stated
    Dec 22 +628 days

    Sold 497,270 shares at $0.99 ($494k)

    Chang Carmen, 10% owner

    Sold 16.2% of holdings ($3M position)2.6M shares leftFirst sale on recordFiling

  3. 3 Form 4 sale GENOCEA BIOSCIENCES, INC.Unusual
    May 25 +154 days

    Sold 10.4M shares at $0.0743 ($771k)

    Chang Carmen, 10% owner

    Sold 100% of holdings ($771k position)0 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale COURPlan not stated
    Mar 15 +294 days

    Sold 1,226 shares at $11.82 ($14k)

    Chang Carmen, Director

    Sold 3.7% of holdings ($388k position)31,640 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale NEUENo plan
    Oct 2 +932 days

    Sold 3,915 shares at $6.75 ($26k)

    Chang Carmen, Director, 10% owner

    No 10b5-1 planSold 0.2% of holdings ($15.3M position)2.3M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Chang Carmen
Source
Oct 2, 2025NEUEDirector, 10% ownerForm 4 sale3,915$26k0.2%No planSEC
Mar 15, 2023COURDirectorForm 4 sale1,226$14k3.7%Plan not statedSEC
May 25, 2022GENOCEA BIOSCIENCES, INC.10% ownerForm 4 sale10.4M$771k100.0%UnusualSEC
Dec 22, 2021Metacrine, Inc.10% ownerForm 4 sale497,270$494k16.2%Plan not statedSEC
Apr 3, 2020TRVI10% ownerForm 4 sale564$2k0.0%Plan not statedSEC